Rain Therapeutics Inc.
NASDAQ:RAIN
1.21 (USD) • At close January 25, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
| Assets: | ||||
| Current Assets: | ||||
| Cash & Cash Equivalents
| 61.955 | 24.78 | 58.863 | 5.794 |
| Short Term Investments
| 68.499 | 115.438 | 0 | 0 |
| Cash and Short Term Investments
| 130.454 | 140.218 | 58.863 | 5.794 |
| Net Receivables
| 0.571 | 0.452 | 0.11 | 0 |
| Inventory
| 2.451 | 5.271 | 0.42 | 0 |
| Other Current Assets
| 0.152 | 0.205 | 0.132 | 0.11 |
| Total Current Assets
| 133.628 | 146.146 | 59.525 | 6.274 |
| Non-Current Assets: | ||||
| Property, Plant & Equipment, Net
| 0.351 | 0.551 | 0.546 | 0.692 |
| Goodwill
| 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 1.201 | 0.443 | 1.009 | 0.429 |
| Total Non-Current Assets
| 1.552 | 0.994 | 1.555 | 1.121 |
| Total Assets
| 135.18 | 147.14 | 61.08 | 7.395 |
| Liabilities & Equity: | ||||
| Current Liabilities: | ||||
| Account Payables
| 7.146 | 6.112 | 0.816 | 0.261 |
| Short Term Debt
| 0.164 | 0.16 | 0.141 | 0.137 |
| Tax Payables
| 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 14.656 | 10.043 | 2.462 | 0.826 |
| Total Current Liabilities
| 21.966 | 16.315 | 3.419 | 1.224 |
| Non-Current Liabilities: | ||||
| Long Term Debt
| 0.113 | 0.252 | 0.312 | 3.175 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.065 | 0.069 | 94.766 | 20.244 |
| Total Non-Current Liabilities
| 0.178 | 0.321 | 95.078 | 23.419 |
| Total Liabilities
| 22.144 | 16.636 | 98.497 | 24.643 |
| Equity: | ||||
| Preferred Stock
| 0 | 147.14 | 0.095 | 0.02 |
| Common Stock
| 0.037 | 0.027 | 0.004 | 0.003 |
| Retained Earnings
| -165.688 | -89.964 | -38.57 | -17.487 |
| Accumulated Other Comprehensive Income/Loss
| -0.166 | -0.089 | -0.095 | -0.02 |
| Other Total Stockholders Equity
| 278.853 | 73.39 | 1.149 | 0.236 |
| Total Shareholders Equity
| 113.036 | 130.504 | -37.417 | -17.248 |
| Total Equity
| 113.036 | 130.504 | -37.417 | -17.248 |
| Total Liabilities & Shareholders Equity
| 135.18 | 147.14 | 61.08 | 7.395 |